Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Human GST P1-1 Redesigned for Enhanced Catalytic Activity with the Anticancer Prodrug Telcyta and Improved Thermostability
Stockholms universitet, Naturvetenskapliga fakulteten, Institutionen för biokemi och biofysik.ORCID-id: 0000-0001-9048-0893
Stockholms universitet, Naturvetenskapliga fakulteten, Institutionen för biokemi och biofysik. Scripps Research, USA.ORCID-id: 0000-0002-6416-064x
Rekke forfattare: 32024 (engelsk)Inngår i: Cancers, ISSN 2072-6694, Vol. 16, nr 4, artikkel-id 762Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Protein engineering can be used to tailor enzymes for medical purposes, including antibody-directed enzyme prodrug therapy (ADEPT), which can act as a tumor-targeted alternative to conventional chemotherapy for cancer. In ADEPT, the antibody serves as a vector, delivering a drug-activating enzyme selectively to the tumor site. Glutathione transferases (GSTs) are a family of naturally occurring detoxication enzymes, and the finding that some of them are overexpressed in tumors has been exploited to develop GST-activated prodrugs. The prodrug Telcyta is activated by GST P1-1, which is the GST most commonly elevated in cancer cells, implying that tumors overexpressing GST P1-1 should be particularly vulnerable to Telcyta. Promising antitumor activity has been noted in clinical trials, but the wildtype enzyme has modest activity with Telcyta, and further functional improvement would enhance its usefulness for ADEPT. We utilized protein engineering to construct human GST P1-1 gene variants in the search for enzymes with enhanced activity with Telcyta. The variant Y109H displayed a 2.9-fold higher enzyme activity compared to the wild-type GST P1-1. However, increased catalytic potency was accompanied by decreased thermal stability of the Y109H enzyme, losing 99% of its activity in 8 min at 50 °C. Thermal stability was restored by four additional mutations simultaneously introduced without loss of the enhanced activity with Telcyta. The mutation Q85R was identified as an important contributor to the regained thermostability. These results represent a first step towards a functional ADEPT application for Telcyta.

sted, utgiver, år, opplag, sider
2024. Vol. 16, nr 4, artikkel-id 762
Emneord [en]
glutathione transferase P1-1, ADEPT, Telcyta, canfosfamide, protein engineering, machine learning, molecular redesign, prodrugs, thermostability
HSV kategori
Identifikatorer
URN: urn:nbn:se:su:diva-227812DOI: 10.3390/cancers16040762ISI: 001172261500001PubMedID: 38398153Scopus ID: 2-s2.0-85185945928OAI: oai:DiVA.org:su-227812DiVA, id: diva2:1847112
Tilgjengelig fra: 2024-03-26 Laget: 2024-03-26 Sist oppdatert: 2025-03-11bibliografisk kontrollert
Inngår i avhandling
1. A study of Pi- and Alpha-class glutathione transferases: Characterization and protein redesign for medical applications
Åpne denne publikasjonen i ny fane eller vindu >>A study of Pi- and Alpha-class glutathione transferases: Characterization and protein redesign for medical applications
2025 (engelsk)Doktoravhandling, med artikler (Annet vitenskapelig)
Abstract [en]

Glutathione transferases (GSTs) are a family of enzymes that are key players in cellular detoxication. These enzymes catalyze the transfer of glutathione (GSH) to the electrophilic center of harmful compounds to promote their elimination.

The human Pi class (GST P1-1) is well-known for its overexpression in cancerous tissue and has been found to contribute to tumor growth and chemotherapeutic resistance. For these reasons, GST P1-1 has emerged as a promising therapeutic target to fight cancer by developing inhibitors and prodrugs (e.g. Telcyta) targeting the enzyme. GST P1-1 has also been suggested as a marker during carcinogenesis.

Apart from being cellular detoxicants some GSTs have come to develop other functions. One member of the human Alpha class, GST A3-3, plays an important role in steroid hormone biosynthesis by catalyzing the double-bond isomerization reaction of 5-androsten-3,17-dione and 5-pregnen-3,20-dione, precursors to the steroid hormones testosterone and progesterone. To date, in addition to the human enzyme, efficient ketosteroid isomerase activity has been identified in Alpha-class enzymes from equine and porcine tissues.

This thesis focuses on studying the Pi- and Alpha-class enzymes. In the first study, we characterize dog GST P1-1 and show that the enzyme shares certain class-specific similarities with the human enzyme in terms of substrate selectivity profile and inhibition profile. We also developed a thin-layer chromatography method to screen and semi-quantify Telcyta activity. In the second study, we show that the replacement of tyrosine109 with histidine increased the activity with the anticancer prodrug Telcyta 2.9-fold, and we also show that the mutation Q85R positively influenced the thermostability of the enzyme. In the third study, we discovered a mutant enzyme, V2 (Q40M-E41Q-A46S-Y109H-V200L), with 22-fold higher catalytic efficiency than wildtype human GST P1-1 with cumene hydroperoxide. The mutation Y109H was responsible for a 10-fold increase in catalytic efficiency. In the fourth study, we discovered that GST A3-3 from the common marmoset monkey possessed prominent ketosteroid isomerase activity, albeit significantly lower than its human and equine counterparts, it was on par with porcine GST A2-2. In the fifth study, we solved the crystal structure of equine GST A3-3 in complex with the inhibitor triethyltin bromide. The structure reveals the interaction between triethyltin bromide, GSH, and Tyr9 in the enzyme.

All in all, the work presented in this thesis has added to the body of knowledge on the glutathione transferases from the Pi- and Alpha-classes.

 

sted, utgiver, år, opplag, sider
Stockholm: Department of Biochemistry and Biophysics, Stockholm University, 2025. s. 52
Emneord
Glutathione transferases, GST A3-3, steroidogenesis, GST P1-1, cancer, Telcyta, enzyme inhibiton, ADEPT, protein engineering
HSV kategori
Forskningsprogram
biokemi
Identifikatorer
urn:nbn:se:su:diva-240646 (URN)978-91-8107-156-6 (ISBN)978-91-8107-157-3 (ISBN)
Disputas
2025-05-19, C458, Kemiska övningslaboratoriet, Svante Arrhenius väg 16 C and online via Zoom, public link is available at the department website, Stockholm, 13:00 (engelsk)
Opponent
Veileder
Tilgjengelig fra: 2025-04-24 Laget: 2025-03-11 Sist oppdatert: 2025-04-08bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Ismail, AramMannervik, Bengt

Søk i DiVA

Av forfatter/redaktør
Ismail, AramMannervik, Bengt
Av organisasjonen
I samme tidsskrift
Cancers

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 61 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf